Cargando…
Targeting MICA with therapeutic antibodies for the treatment of cancer
Autores principales: | Bonnafous, Cécile, Peri, Valentine, Trichard, Sylvia, Perrot, Ivan, Cornen, Stéphanie, Thielens, Ariane, Breso, Violette, Morel, Yannis, Rossi, Benjamin, Paturel, Carine, Gauthier, Laurent, Bléry, Mathieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990990/ http://dx.doi.org/10.1186/2051-1426-1-S1-P41 |
Ejemplares similares
-
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control
por: Bléry, Mathieu, et al.
Publicado: (2021) -
Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model
por: Sola, Caroline, et al.
Publicado: (2013) -
Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T cell lymphomas
por: Marie-Cardine, Anne, et al.
Publicado: (2013) -
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
por: André, Pascale, et al.
Publicado: (2018) -
S258: IPH6501 IS A FIRST-IN-CLASS TETRASPECIFIC ANTIBODY-BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B-CELL NON-HODGKIN’S LYMPHOMAS
por: Demaria, Olivier, et al.
Publicado: (2023)